Form 4: Hayward Holdings CEO Kevin Holleran Executes Stock Options and Sells Shares
SEC Form 4 Filing
Hayward Holdings CEO Kevin Holleran exercised stock options and sold a portion of the acquired shares on July 2, 2024.
Summary
- On July 2, 2024, Kevin Holleran, the President and CEO of Hayward Holdings, Inc., exercised stock options to acquire 42,857 shares of common stock at a price of $1.40 per share.
- Simultaneously, Holleran sold 42,857 shares of common stock at a weighted average price of $12.1259, with individual transactions ranging from $12.08 to $12.18.
- Following these transactions, Holleran directly owns 522,799 shares of Hayward Holdings common stock.
- He also indirectly owns 700 shares each through Child A, Child B, and Child C.
- Holleran continues to hold options to purchase 3,424,285 shares of common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives. It's common for executives to exercise stock options and sell a portion of the shares for personal financial management.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their executives.
- The details provided are consistent with regulatory requirements for disclosing insider transactions.
- Comparable companies like Pentair or Pool Corporation would have similar filings when their executives trade company stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership.
- The impact on employees, customers, suppliers, and creditors is likely negligible.
Key Dates
| Date | Description |
|---|---|
| 07/02/2024 | Date of stock option exercise and share sale. |
| 07/03/2024 | Date of signature by attorney-in-fact. |
| 12/24/2029 | Expiration date of stock options. |
| 08/12/2024 | Date of vesting of the remaining 10% of the initial underlying shares of Common Stock initially awarded. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.